{"title": "NewsRamp Curated News Feed for Health Wellness", "description": "NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.", "site_url": "https://www.newsramp.com", "display_name": "NewsRamp.com", "next_page": "https://feeds.newsramp.net/tldr/newsramp/moderated/10/2/health-wellness.json", "instructions": "Fine tune the feed as follows /tldr/category/newsramp/en/all/20/1/health-wellness.json /tldr/category/en/[all/moderated]/[records per page up to 100]/[page number]/health-wellness.json - Available Language Codes English=en", "prev_page": "", "current_page": 1, "total_records": 5984, "total_pages": 599, "image_url": "https://newsramp.com/light-logo.svg", "language": "en", "ttl": 10, "news": [{"feed_item_id": 37453, "prhash_id": "778c28c520f8b53c8141c5b6353cc452", "headline": "Gamblin Orthodontics Expands Clear Aligner and Digital Scanning Options for Teens and Adults", "content": "        <article>        <h1>Gamblin Orthodontics Expands Clear Aligner and Digital Scanning Options for Teens and Adults</h1>        <img src='https://cdn.newsramp.app/press-services/newsimage/778c28c520f8b53c8141c5b6353cc452.jpg' style='width:80%; display: block; margin-left: auto; margin-right: auto; margin-top:1rem; margin-bottom:1rem;' alt='Gamblin Orthodontics Expands Clear Aligner and Digital Scanning Options for Teens and Adults'/>        <h2>Key Takeaways (TLDR)</h2>        <ul>            <li>Gamblin Orthodontics now offers clear aligners and adult braces with digital scanning, giving Ridgeland patients an edge in discreet, efficient treatment.</li>            <li>Gamblin Orthodontics uses digital scanning to replace traditional impressions, providing precise teeth images and treatment simulations for teens and adults in Ridgeland.</li>            <li>Gamblin Orthodontics expands teen and adult orthodontic care with flexible scheduling, reducing treatment disruption for busy families in the Jackson metro.</li>            <li>Gamblin Orthodontics in Ridgeland introduces digital scanning, making orthodontic impressions more comfortable for teens and adults, a modern upgrade for patients.</li>        </ul>        <h2>Why it Matters</h2>        <p>This news matters because it highlights a growing trend in orthodontics toward patient-centric, technology-driven care that prioritizes comfort and convenience. For teens and adults in the Ridgeland area, this means access to discreet treatment options like clear aligners and modern braces, which can significantly improve their experience and satisfaction. The adoption of digital scanning not only reduces discomfort but also empowers patients with visual simulations, helping them make confident decisions about their care. Flexible scheduling further removes barriers, making orthodontic treatment more accessible for busy families and professionals. Ultimately, this development reflects a broader shift in healthcare toward personalized, efficient services that cater to the modern patient's needs.</p>        <h2>Summary</h2>        <p><p>Gamblin Orthodontics, a leading orthodontic practice in Ridgeland, Mississippi, has announced an expanded focus on serving teenagers and adults with a range of modern treatment options, including clear aligners and advanced braces. The practice now emphasizes <a href='https://www.gamblinortho.net/clarity-aligners' rel='noopener noreferrer'>clear aligners for teens in Ridgeland MS</a> and contemporary braces tailored to adult needs, all supported by cutting-edge digital scanning technology. This shift recognizes the unique priorities of older patients who seek discreet, efficient solutions that fit seamlessly into their busy lifestyles, whether they are navigating school schedules or professional commitments.</p><p>Dr. Jeff Gamblin, the orthodontist behind the practice, is known for his patient-centered approach and has positioned Gamblin Orthodontics as a go-to <a href='https://www.gamblinortho.net/meet-dr-jeff-gamblin' rel='noopener noreferrer'>orthodontist in Ridgeland MS</a>. The practice's updated offerings include clear aligners, which are removable trays that offer a nearly invisible way to straighten teeth, and <a href='https://www.gamblinortho.net/life-with-braces' rel='noopener noreferrer'>braces for adults in Ridgeland MS</a>, which are designed with considerations like bone density and existing dental work in mind. To enhance the patient experience, Gamblin Orthodontics has replaced traditional putty impressions with digital scanning, which not only improves comfort but also allows for precise treatment simulations. This technology gives patients a clear preview of their expected results, fostering more informed decision-making.</p><p>Understanding the demands of modern life, the practice has also <a href='https://www.gamblinortho.net/ridgeland' rel='noopener noreferrer'>structured its scheduling</a> to be flexible, accommodating families and professionals across the Jackson metro area. Whether patients are coming from Ridgeland or surrounding communities, the practice aims to minimize disruptions to their daily routines. Gamblin Orthodontics continues to serve a broad patient base, offering everything from early intervention for children to comprehensive care for teens and adults. For more information, visit <a href='https://www.gamblinortho.net/' rel='noopener noreferrer'>Gamblin Orthodontics</a>.</p></p>        <div><a href='https://newsramp.com/blockchain/txn_detail/778c28c520f8b53c8141c5b6353cc452.37453.bcuuid 'style='display: flex; align-items: flex-start;'><img src='https://cdn.newsramp.net/qrcode/778c28c520f8b53c8141c5b6353cc452.webp' class='newsramp-qrcode' style='width: 200px; max-width: 300px; margin-bottom: 25px;'  alt='Blockchain Registration, Verification & Enhancement provided by NewsRamp\u2122'/></a><p>This news story relied on content distributed by <a href='https://mediawiretoday.com'>Press Services</a>.  Blockchain Registration, Verification &amp; Enhancement provided by <a href='https://newsramp.com'>NewsRamp\u2122.</a> The source URL for this press release is <a href='https://newsramp.com/news/press-services/en/clear-aligners-and-modern-braces-now-available-for-teens-and-adults-444810/778c28c520f8b53c8141c5b6353cc452'>Gamblin Orthodontics Expands Clear Aligner and Digital Scanning Options for Teens and Adults.</a></p></div>        </article>    ", "published": "2026-08-19T10:20:00+00:00", "audio_release": "https://cdn.newsramp.net/audio/778c28c520f8b53c8141c5b6353cc452.mp3", "blockchain_qrcode": "https://cdn.newsramp.net/qrcode/778c28c520f8b53c8141c5b6353cc452.webp", "enclosure": "https://cdn.newsramp.app/press-services/newsimage/778c28c520f8b53c8141c5b6353cc452.jpg", "site_handle": "press-services", "seo_description": "Discover clear aligners and modern braces for teens and adults at Gamblin Orthodontics in Ridgeland, MS. Enjoy digital scanning and flexible scheduling. Book your consultation today!", "newsramp_curated": "https://newsramp.com/curated-news/gamblin-orthodontics-expands-clear-aligner-and-digital-scanning-options-for-teens-and-adults/778c28c520f8b53c8141c5b6353cc452"}, {"feed_item_id": 37427, "prhash_id": "1b7ad62535cd90963e0949b562e80d2d", "headline": "BridgeInteract Achieves SOC 2 Type 2 Certification, Bolstering Healthcare Data Security", "content": "        <article>        <h1>BridgeInteract Achieves SOC 2 Type 2 Certification, Bolstering Healthcare Data Security</h1>        <img src='https://cdn.newsramp.app/banners/health-wellness-3.jpg' style='width:80%; display: block; margin-left: auto; margin-right: auto; margin-top:1rem; margin-bottom:1rem;' alt='BridgeInteract Achieves SOC 2 Type 2 Certification, Bolstering Healthcare Data Security'/>        <h2>Key Takeaways (TLDR)</h2>        <ul>            <li>BridgeInteract's SOC 2 Type 2 report proves a track record of security, giving providers a competitive edge in vendor selection.</li>            <li>BridgeInteract completed a SOC 2 Type 2 audit, testing controls over months, not a single date, to ensure effective security operations.</li>            <li>BridgeInteract's security certification protects patient data across unified platforms, fostering trust and better healthcare experiences.</li>            <li>BridgeInteract's SOC 2 Type 2 report is like a security report card, showing months of consistent controls, not just a one-day snapshot.</li>        </ul>        <h2>Why it Matters</h2>        <p>In an era where healthcare data breaches are increasingly common, BridgeInteract's SOC 2 Type 2 certification provides a critical assurance for healthcare organizations. This independent validation of security controls over time means that patient data is protected not just in theory but in practice, reducing the risk of costly breaches and reputational damage. For providers, this translates to greater trust from patients and a more robust compliance posture, while patients can feel more confident that their sensitive information is safeguarded.</p>        <h2>Summary</h2>        <p><p>BridgeInteract, a healthcare technology company, announced that it has successfully completed a SOC 2 Type 2 examination, a rigorous audit that verifies the effectiveness of its security controls over a period of time. The examination, conducted by an independent CPA firm, tested the company's controls against the trust services criteria of security, availability, processing integrity, confidentiality, and privacy. This achievement underscores BridgeInteract's commitment to protecting sensitive patient information.</p><p>The SOC 2 Type 2 report is a significant milestone for the company, as it goes beyond a Type 1 report that only checks control design at a single point in time. Instead, it validates that the controls have been operating effectively over months, providing healthcare organizations with confidence in the platform's security. John Deutsch, CEO of BridgeInteract, emphasized that the Type 2 examination is the standard customers deserve, as it demonstrates a track record of security, not just a snapshot.</p><p>BridgeInteract's platform unifies patient portal, intake, payments, scheduling, clinical and social-needs screening, and secure messaging, all integrated directly into the EHR. By consolidating multiple systems, the company reduces points of exposure for healthcare organizations. The platform's security is further reinforced by its compliance with ONC Certification Criteria, HIPAA, and PIPEDA for Canadian clients. BridgeInteract also engages independent security firms for ongoing testing, ensuring security is a continuous priority. For more information, visit <a href='https://www.bridgeinteract.io' rel='nofollow'>https://www.bridgeinteract.io</a>.</p></p>        <div><a href='https://newsramp.com/blockchain/txn_detail/1b7ad62535cd90963e0949b562e80d2d.37427.bcuuid 'style='display: flex; align-items: flex-start;'><img src='https://cdn.newsramp.net/qrcode/1b7ad62535cd90963e0949b562e80d2d.webp' class='newsramp-qrcode' style='width: 200px; max-width: 300px; margin-bottom: 25px;'  alt='Blockchain Registration, Verification & Enhancement provided by NewsRamp\u2122'/></a><p>This news story relied on content distributed by <a href='https://24-7pressrelease.com'>24-7 Press Release</a>.  Blockchain Registration, Verification &amp; Enhancement provided by <a href='https://newsramp.com'>NewsRamp\u2122.</a> The source URL for this press release is <a href='https://newsramp.com/news/24-7PressRelease/en/bridgeinteract-completes-soc-2-type-2-examination/1b7ad62535cd90963e0949b562e80d2d'>BridgeInteract Achieves SOC 2 Type 2 Certification, Bolstering Healthcare Data Security.</a></p></div>        </article>    ", "published": "2026-08-19T07:00:00+00:00", "audio_release": "https://cdn.newsramp.net/audio/1b7ad62535cd90963e0949b562e80d2d.mp3", "blockchain_qrcode": "https://cdn.newsramp.net/qrcode/1b7ad62535cd90963e0949b562e80d2d.webp", "enclosure": "https://cdn.newsramp.app/banners/health-wellness-3.jpg", "site_handle": "24-7PressRelease", "seo_description": "BridgeInteract, a healthcare technology company, announces SOC 2 Type 2 certification, demonstrating robust security controls over time. Learn how this enhances patient data protection.", "newsramp_curated": "https://newsramp.com/curated-news/bridgeinteract-achieves-soc-2-type-2-certification-bolstering-healthcare-data-security/1b7ad62535cd90963e0949b562e80d2d"}, {"feed_item_id": 37434, "prhash_id": "4e59d2afd73e2611e4fffc5c542352bd", "headline": "CCHR Exhibit Exposes Psychiatric Abuses in St. Paul, Calls for Reform", "content": "        <article>        <h1>CCHR Exhibit Exposes Psychiatric Abuses in St. Paul, Calls for Reform</h1>        <img src='https://cdn.newsramp.app/banners/events-7.jpg' style='width:80%; display: block; margin-left: auto; margin-right: auto; margin-top:1rem; margin-bottom:1rem;' alt='CCHR Exhibit Exposes Psychiatric Abuses in St. Paul, Calls for Reform'/>        <h2>Key Takeaways (TLDR)</h2>        <ul>            <li>CCHR's exhibit exposes psychiatric abuses, giving advocates leverage to push for legislative changes and protect patients' rights.</li>            <li>The exhibit uses 14 panels and 13 documentaries to detail psychiatric abuses, and Dr. Nerad proposes a coalition to revise Minnesota's civil commitment laws.</li>            <li>The exhibit aims to protect vulnerable patients from involuntary drugging and detention, fostering a safer and more humane mental health system.</li>            <li>Discover how CCHR, co-founded by Thomas Szasz and the Church of Scientology, links psychiatric drugs to mass shootings in its latest documentary.</li>        </ul>        <h2>Why it Matters</h2>        <p>This news matters because it sheds light on potential human rights violations within the mental health system, particularly regarding civil commitments. The exhibit and coalition aim to reform laws to protect vulnerable individuals from being drugged or detained without consent. Understanding these issues is crucial for anyone concerned about patient rights, mental health care ethics, and the safety of society. The documentary's claim linking psychiatric drugs to violence has significant implications for public safety and could influence policy debates on mental health treatment and gun control.</p>        <h2>Summary</h2>        <p><p>The Citizens Commission on Human Rights (CCHR) opened its traveling exhibit, 'Psychiatry an Industry of Death,' in downtown St. Paul, Minnesota, at the Nova Event Hall on St Peter St. The exhibit features 14 graphic panels and 13 short documentaries that expose historical and current abuses in the mental health field. An opening ribbon-cutting ceremony on Monday drew an excited crowd and featured guest speakers who highlighted the horrors of civil commitment, including patients being held against their will, drugged without informed consent, and subjected to human rights violations. Dr. Patrice Nerad, the main speaker, called for the formation of a coalition to change Minnesota's civil commitment laws to protect patients from harm in the name of help. The CCHR Minnesota chapter will assist in establishing and guiding this coalition.</p><p>CCHR, an international watchdog over the psychiatric industry since 1969, has worked globally to reform legislation that curtails psychiatric overreach into education and society. The exhibit's title reflects its content, which includes documentaries linking psychiatric drugs to violence, particularly mass shootings. The most recent documentary argues that psychiatric drugs are a cause of violence in society. For more information, visit the <a href='https://www.cchr.org/' rel='nofollow'>CCHR website</a>, watch documentaries on the work of <a href='https://www.scientology.tv/series/voices-for-humanity/' rel='nofollow'>CCHR volunteers in countries around the world</a>, and see the film <a href='https://www.scientology.tv/series/cchr-documentaries/psychiatry-an-industry-of-death.html' rel='nofollow'>Psychiatry: An Industry of Death</a> on the Scientology Network. CCHR was co-founded in 1969 by psychiatrist Dr. Thomas Szasz and the Church of Scientology, and its commissioners include physicians, psychiatrists, psychologists, lawyers, legislators, government officials, educators, and civil rights representatives. The organization is inspired by L. Ron Hubbard's commitment to abolishing physically damaging practices in mental health.</p></p>        <div><a href='https://newsramp.com/blockchain/txn_detail/4e59d2afd73e2611e4fffc5c542352bd.37434.bcuuid 'style='display: flex; align-items: flex-start;'><img src='https://cdn.newsramp.net/qrcode/4e59d2afd73e2611e4fffc5c542352bd.webp' class='newsramp-qrcode' style='width: 200px; max-width: 300px; margin-bottom: 25px;'  alt='Blockchain Registration, Verification & Enhancement provided by NewsRamp\u2122'/></a><p>This news story relied on content distributed by <a href='https://24-7pressrelease.com'>24-7 Press Release</a>.  Blockchain Registration, Verification &amp; Enhancement provided by <a href='https://newsramp.com'>NewsRamp\u2122.</a> The source URL for this press release is <a href='https://newsramp.com/news/24-7PressRelease/en/citizens-commission-on-human-rights-meets-twin-cities/4e59d2afd73e2611e4fffc5c542352bd'>CCHR Exhibit Exposes Psychiatric Abuses in St. Paul, Calls for Reform.</a></p></div>        </article>    ", "published": "2026-08-19T07:00:00+00:00", "audio_release": "https://cdn.newsramp.net/audio/4e59d2afd73e2611e4fffc5c542352bd.mp3", "blockchain_qrcode": "https://cdn.newsramp.net/qrcode/4e59d2afd73e2611e4fffc5c542352bd.webp", "enclosure": "https://cdn.newsramp.app/banners/events-7.jpg", "site_handle": "24-7PressRelease", "seo_description": "CCHR's traveling exhibit 'Psychiatry an Industry of Death' opens in St. Paul, exposing abuses in mental health and calling for civil commitment law reform.", "newsramp_curated": "https://newsramp.com/curated-news/cchr-exhibit-exposes-psychiatric-abuses-in-st-paul-calls-for-reform/4e59d2afd73e2611e4fffc5c542352bd"}, {"feed_item_id": 37437, "prhash_id": "ad6993088f9a646e6eac971345920b91", "headline": "Invisalign for Teens: Discreet Orthodontics in Port Coquitlam", "content": "        <article>        <h1>Invisalign for Teens: Discreet Orthodontics in Port Coquitlam</h1>        <img src='https://cdn.newsramp.app/banners/consumer-lifestyle-1.jpg' style='width:80%; display: block; margin-left: auto; margin-right: auto; margin-top:1rem; margin-bottom:1rem;' alt='Invisalign for Teens: Discreet Orthodontics in Port Coquitlam'/>        <h2>Key Takeaways (TLDR)</h2>        <ul>            <li>Invisalign Teen at Innova Ortho offers teens a discreet, removable aligner advantage over traditional braces, keeping them active and confident.</li>            <li>Innova Ortho uses advanced digital planning and compliance indicators to customize Invisalign Teen treatment, guiding tooth movement for growing smiles.</li>            <li>Invisalign Teen helps teens maintain self-esteem by providing a comfortable, discreet orthodontic option that doesn't disrupt their social life or activities.</li>            <li>Invisalign Teen aligners are virtually invisible and removable, allowing teens to eat, brush, and play sports without the hassle of brackets and wires.</li>        </ul>        <h2>Why it Matters</h2>        <p>This news matters because it highlights a modern orthodontic solution that addresses the unique needs of teenagers, who often struggle with the aesthetic and practical challenges of traditional braces. Invisalign Teen offers a discreet, removable option that allows teens to maintain their active lifestyles, social confidence, and oral hygiene without the discomfort and visibility of metal brackets. For parents, this means a more appealing treatment that can improve their teen's self-esteem and compliance, potentially leading to better orthodontic outcomes. For the community, it underscores the availability of advanced dental care in Port Coquitlam, making it easier for families to access innovative treatments that enhance quality of life.</p>        <h2>Summary</h2>        <p><p>For many teenagers, the thought of getting braces can feel overwhelming, with concerns about appearance, sports, and social events often making orthodontic treatment seem like an inconvenience. Innova Ortho, a leading orthodontic practice in Port Coquitlam, BC, offers a modern solution with <a href='https://www.innovaortho.com/invisalign/invisalign-teen/' rel='nofollow'>Invisalign for Teens in Port Coquitlam</a>, designed to straighten smiles while fitting seamlessly into an active lifestyle. As a certified provider of <a href='https://www.innovaortho.com/invisalign/invisalign-teen/' rel='nofollow'>Invisalign for Teens</a>, Innova Ortho provides customized treatment using clear, removable aligners that are virtually invisible, comfortable, and allow teens to continue enjoying their favorite foods, activities, and social moments with confidence. Unlike traditional metal braces, Invisalign Teen aligners can be removed when eating, brushing, flossing, or participating in sports, offering flexibility that fits busy schedules filled with school, music, and friendships.</p><p>Every smile is unique, so treatment begins with a personalized consultation where the orthodontic team evaluates each patient's bite, alignment concerns, and treatment goals. The system uses advanced digital treatment planning to guide tooth movement and includes compliance indicators that help teens and orthodontists monitor wear. This ensures that teens can work toward a straighter smile discreetly and comfortably, without the appearance of brackets and wires. Whether preparing for a big event or playing competitive sports, Invisalign Teen provides a way to improve oral health and self-esteem without putting life on hold.</p><p>Parents and teens interested in learning more are invited to schedule a consultation with Innova Orthodontics, where the team will assess the smile, discuss options, and answer questions. To get started, call (604) 474-1141 or <a href='https://www.innovaortho.com/contact/' rel='nofollow'>visit the contact page</a>. Led by Port Coquitlam orthodontists Dr. Lun Wang, Dr. Kevin Lee, and Dr. Yan Liu, Innova Ortho offers braces, Invisalign, and other treatments. For more information, visit <a href='https://www.innovaortho.com' rel='nofollow'>https://www.innovaortho.com</a>.</p></p>        <div><a href='https://newsramp.com/blockchain/txn_detail/ad6993088f9a646e6eac971345920b91.37437.bcuuid 'style='display: flex; align-items: flex-start;'><img src='https://cdn.newsramp.net/qrcode/ad6993088f9a646e6eac971345920b91.webp' class='newsramp-qrcode' style='width: 200px; max-width: 300px; margin-bottom: 25px;'  alt='Blockchain Registration, Verification & Enhancement provided by NewsRamp\u2122'/></a><p>This news story relied on content distributed by <a href='https://24-7pressrelease.com'>24-7 Press Release</a>.  Blockchain Registration, Verification &amp; Enhancement provided by <a href='https://newsramp.com'>NewsRamp\u2122.</a> The source URL for this press release is <a href='https://newsramp.com/news/24-7PressRelease/en/invisalign-for-teens-means-confident-comfortable-smiles/ad6993088f9a646e6eac971345920b91'>Invisalign for Teens: Discreet Orthodontics in Port Coquitlam.</a></p></div>        </article>    ", "published": "2026-08-19T07:00:00+00:00", "audio_release": "https://cdn.newsramp.net/audio/ad6993088f9a646e6eac971345920b91.mp3", "blockchain_qrcode": "https://cdn.newsramp.net/qrcode/ad6993088f9a646e6eac971345920b91.webp", "enclosure": "https://cdn.newsramp.app/banners/consumer-lifestyle-1.jpg", "site_handle": "24-7PressRelease", "seo_description": "Discover Invisalign for Teens in Port Coquitlam at Innova Ortho. Clear aligners for a confident smile. Book a consultation today!", "newsramp_curated": "https://newsramp.com/curated-news/invisalign-for-teens-discreet-orthodontics-in-port-coquitlam/ad6993088f9a646e6eac971345920b91"}, {"feed_item_id": 37428, "prhash_id": "2b36a72208ed095b5f1822a68d257413", "headline": "Chicago Law Firm Lane Brown, LLC Champions Victims of Injury and Abuse", "content": "        <article>        <h1>Chicago Law Firm Lane Brown, LLC Champions Victims of Injury and Abuse</h1>        <img src='https://cdn.newsramp.app/banners/legal-5.jpg' style='width:80%; display: block; margin-left: auto; margin-right: auto; margin-top:1rem; margin-bottom:1rem;' alt='Chicago Law Firm Lane Brown, LLC Champions Victims of Injury and Abuse'/>        <h2>Key Takeaways (TLDR)</h2>        <ul>            <li>Lane Brown, LLC leverages decades of trial experience to secure maximum compensation for personal injury and sexual abuse survivors, giving clients a strategic advantage in civil litigation.</li>            <li>Lane Brown, LLC employs a systematic approach: free consultations, contingency fees, evidence gathering, expert testimony, and trial preparation to build robust civil cases for clients in Illinois.</li>            <li>Lane Brown, LLC empowers survivors and injury victims by providing a supportive legal path to financial recovery and accountability, helping them rebuild their lives with dignity.</li>            <li>Did you know civil lawsuits can compensate sexual abuse survivors for therapy and lost income, even when criminal charges aren't filed? Lane Brown, LLC explains this often-overlooked avenue.</li>        </ul>        <h2>Why it Matters</h2>        <p>This news matters because it highlights the crucial role civil litigation plays in helping victims of personal injury and sexual abuse achieve accountability and financial recovery. For survivors, civil lawsuits can provide a sense of justice that the criminal justice system may not offer, as well as essential resources for long-term care and healing. By understanding their legal options, individuals and families can make informed decisions and seek the support they need to rebuild their lives.</p>        <h2>Summary</h2>        <p><p>Chicago-based personal injury law firm Lane Brown, LLC is reaffirming its commitment to representing victims of negligence and sexual abuse across Illinois. With decades of combined trial experience, the firm handles cases involving catastrophic injuries, medical malpractice, motor vehicle accidents, and wrongful death. For survivors of sexual abuse, the firm offers a path to civil justice, which can provide financial compensation for medical care, therapy, lost income, and emotional distress, while also holding perpetrators and negligent institutions accountable. As partner Mark A. Brown notes, 'Many survivors do not realize that civil court gives them a real voice and a direct path to accountability.'</p><p>In the realm of personal injury, Lane Brown, LLC stands out for its client-first approach, offering free initial consultations and working on a contingency fee basis, meaning clients pay no legal fees unless the firm secures a recovery. The team, led by partners Scott D. Lane and Mark A. Brown, is known for its tenacity in negotiating with insurance companies and preparing cases for trial when necessary. Scott D. Lane emphasizes, 'When someone gets hurt because of another party's carelessness, doing the right thing means making sure the victim is not left carrying the financial burden alone.'</p><p>Lane Brown, LLC, located in downtown Chicago, serves clients throughout Illinois, providing legal representation that prioritizes trust and communication. Whether dealing with the aftermath of a serious accident or the trauma of abuse, the firm aims to empower clients with clear legal options and dedicated advocacy. For more information, visit <a href='https://www.lanebrownlaw.com/' rel='nofollow'>Lane Brown, LLC</a>.</p></p>        <div><a href='https://newsramp.com/blockchain/txn_detail/2b36a72208ed095b5f1822a68d257413.37428.bcuuid 'style='display: flex; align-items: flex-start;'><img src='https://cdn.newsramp.net/qrcode/2b36a72208ed095b5f1822a68d257413.webp' class='newsramp-qrcode' style='width: 200px; max-width: 300px; margin-bottom: 25px;'  alt='Blockchain Registration, Verification & Enhancement provided by NewsRamp\u2122'/></a><p>This news story relied on content distributed by <a href='https://24-7pressrelease.com'>24-7 Press Release</a>.  Blockchain Registration, Verification &amp; Enhancement provided by <a href='https://newsramp.com'>NewsRamp\u2122.</a> The source URL for this press release is <a href='https://newsramp.com/news/24-7PressRelease/en/chicago-law-firm-lane-brown-llc-expands-advocacy-for-personal-injury-victims-and-survivors-of-sexual-abuse/2b36a72208ed095b5f1822a68d257413'>Chicago Law Firm Lane Brown, LLC Champions Victims of Injury and Abuse.</a></p></div>        </article>    ", "published": "2026-08-19T07:00:00+00:00", "audio_release": "https://cdn.newsramp.net/audio/2b36a72208ed095b5f1822a68d257413.mp3", "blockchain_qrcode": "https://cdn.newsramp.net/qrcode/2b36a72208ed095b5f1822a68d257413.webp", "enclosure": "https://cdn.newsramp.app/banners/legal-5.jpg", "site_handle": "24-7PressRelease", "seo_description": "Lane Brown, LLC, a Chicago personal injury law firm, advocates for victims of negligence and sexual abuse, offering contingency fee representation and free consultations.", "newsramp_curated": "https://newsramp.com/curated-news/chicago-law-firm-lane-brown-llc-champions-victims-of-injury-and-abuse/2b36a72208ed095b5f1822a68d257413"}, {"feed_item_id": 37440, "prhash_id": "ddcae9f329296a02289718810fdabd75", "headline": "Professional Teeth Whitening: A Safer Path to a Brighter Smile", "content": "        <article>        <h1>Professional Teeth Whitening: A Safer Path to a Brighter Smile</h1>        <img src='https://cdn.newsramp.app/banners/health-wellness-5.jpg' style='width:80%; display: block; margin-left: auto; margin-right: auto; margin-top:1rem; margin-bottom:1rem;' alt='Professional Teeth Whitening: A Safer Path to a Brighter Smile'/>        <h2>Key Takeaways (TLDR)</h2>        <ul>            <li>Professional teeth whitening at T\u00dcTH Dental offers predictable results and expert supervision, giving patients a confident smile that stands out in personal and professional settings.</li>            <li>T\u00dcTH Dental's professional whitening begins with an oral health assessment, uses clinical-strength gels with desensitizing agents, and includes monitoring for safe, customized results.</li>            <li>T\u00dcTH Dental prioritizes patient safety and comfort, ensuring a brighter smile that boosts confidence while protecting long-term oral health for a better tomorrow.</li>            <li>T\u00dcTH Dental's Dr. Royce Yang has completed over 100 full-mouth rehab cases and offers whitening with built-in sensitivity reduction for a comfortable experience.</li>        </ul>        <h2>Why it Matters</h2>        <p>This news matters because it educates consumers about the potential risks of at-home whitening kits and emphasizes the importance of professional supervision for safe and effective results. By choosing professional teeth whitening, individuals can avoid common problems like gum irritation and patchy outcomes, while benefiting from customized treatments that protect their oral health. T\u00dcTH Dental's expertise, led by Dr. Royce Yang, ensures that patients receive high-quality care, ultimately leading to greater confidence and satisfaction with their smiles.</p>        <h2>Summary</h2>        <p><p>In the quest for a brighter smile, many people turn to over-the-counter whitening products, but these can often lead to unsatisfactory results or oral health issues. T\u00dcTH Dental, a Richmond-based dental clinic led by Dr. Royce Yang, is highlighting the advantages of professional teeth whitening. Unlike generic kits, professional treatments begin with a thorough assessment of a patient's oral health, identifying potential issues such as cavities or gum concerns that could affect whitening outcomes. The clinic uses clinical-strength whitening gels with built-in desensitizing agents and other sensitivity-reduction measures to ensure comfort. Dr. Yang, who has completed over 100 full-mouth rehabilitation cases and treated more than 4,000 patients, emphasizes the importance of expert supervision in achieving predictable, natural-looking results while protecting long-term oral health.</p><p>Professional teeth whitening offers several benefits over DIY methods, including customization, comfort, and predictable outcomes. At T\u00dcTH Dental, treatments are tailored to each patient's needs, and the process is monitored by dental professionals to protect sensitive gum tissues and manage sensitivity concerns. The clinic's approach combines modern technology with patient-focused care, ensuring that each individual receives comprehensive and transparent treatment. For those considering teeth whitening, the clinic recommends a consultation to discuss goals and explore safe cosmetic dentistry options. With a focus on safety and effectiveness, T\u00dcTH Dental is dedicated to helping patients achieve healthier, more confident smiles.</p></p>        <div><a href='https://newsramp.com/blockchain/txn_detail/ddcae9f329296a02289718810fdabd75.37440.bcuuid 'style='display: flex; align-items: flex-start;'><img src='https://cdn.newsramp.net/qrcode/ddcae9f329296a02289718810fdabd75.webp' class='newsramp-qrcode' style='width: 200px; max-width: 300px; margin-bottom: 25px;'  alt='Blockchain Registration, Verification & Enhancement provided by NewsRamp\u2122'/></a><p>This news story relied on content distributed by <a href='https://24-7pressrelease.com'>24-7 Press Release</a>.  Blockchain Registration, Verification &amp; Enhancement provided by <a href='https://newsramp.com'>NewsRamp\u2122.</a> The source URL for this press release is <a href='https://newsramp.com/news/24-7PressRelease/en/the-importance-of-safe-professional-teeth-whitening-for-a-brighter-healthier-smile/ddcae9f329296a02289718810fdabd75'>Professional Teeth Whitening: A Safer Path to a Brighter Smile.</a></p></div>        </article>    ", "published": "2026-08-19T07:00:00+00:00", "audio_release": "https://cdn.newsramp.net/audio/ddcae9f329296a02289718810fdabd75.mp3", "blockchain_qrcode": "https://cdn.newsramp.net/qrcode/ddcae9f329296a02289718810fdabd75.webp", "enclosure": "https://cdn.newsramp.app/banners/health-wellness-5.jpg", "site_handle": "24-7PressRelease", "seo_description": "Discover why professional teeth whitening in Richmond, BC, is safer and more effective than DIY kits. T\u00dcTH Dental offers customized, comfortable treatments for a brighter smile.", "newsramp_curated": "https://newsramp.com/curated-news/professional-teeth-whitening-a-safer-path-to-a-brighter-smile/ddcae9f329296a02289718810fdabd75"}, {"feed_item_id": 37426, "prhash_id": "b4a57379a98a1b5294abf4271d3e0646", "headline": "Belfast Vascular Surgeon Expands to 850+ Procedures Annually", "content": "        <article>        <h1>Belfast Vascular Surgeon Expands to 850+ Procedures Annually</h1>        <img src='https://cdn.newsramp.app/press-services/newsimage/b4a57379a98a1b5294abf4271d3e0646.jpg' style='width:80%; display: block; margin-left: auto; margin-right: auto; margin-top:1rem; margin-bottom:1rem;' alt='Belfast Vascular Surgeon Expands to 850+ Procedures Annually'/>        <h2>Key Takeaways (TLDR)</h2>        <ul>            <li>Professor O'Donnell's practice performs over 850 procedures yearly, offering direct access to a consultant without GP referral, reducing waiting times.</li>            <li>Radiofrequency ablation, foam sclerotherapy, and open surgery are used, with same consultant from assessment to follow-up, ensuring consistent care.</li>            <li>Patients in Northern Ireland gain timely, consultant-led care, avoiding long NHS waits and improving quality of life for those with venous conditions.</li>            <li>A Belfast surgeon now performs over 850 minimally invasive procedures annually, using heat or foam to treat varicose veins without general anesthesia.</li>        </ul>        <h2>Why it Matters</h2>        <p>This news matters for patients in Northern Ireland suffering from venous conditions like varicose veins. It highlights the availability of timely, consultant-led care in the private sector, which can reduce the burden on the NHS and offer quicker relief from symptoms. The expansion means more individuals can access specialized treatment without long waits, potentially avoiding complications such as chronic pain or ulcers. It also underscores the importance of experienced surgeons performing high volumes of procedures, which can lead to better outcomes and patient satisfaction.</p>        <h2>Summary</h2>        <p><p>Professor Mark O'Donnell, a consultant vascular surgeon based in Belfast, has expanded his private practice capacity to perform over 850 minimally invasive vascular procedures annually across Northern Ireland. With more than two decades of specialist vascular expertise, he offers direct access to consultant-led care, focusing on venous conditions, particularly varicose veins. His practice is structured so that each patient is assessed, treated, and followed up by the same specialist, ensuring continuity and personalized attention. This model contrasts with larger institutional settings where care is often distributed among multiple practitioners.</p><p>The practice provides a range of minimally invasive techniques, including radiofrequency ablation and foam sclerotherapy, as well as open surgery for complex cases. This comprehensive approach to varicose veins treatment in Northern Ireland means patients can receive appropriate care without needing referrals elsewhere. The expansion comes as more patients seek private vascular assessment due to long NHS waiting times. Professor O'Donnell's Belfast-based practice offers prompt consultant assessment without requiring a GP referral, allowing individuals to begin diagnosis quickly. With over 850 procedures performed each year, the practice demonstrates high-volume expertise, which is associated with reliable outcomes. For more information, visit <a href='https://www.markodonnellvascularsurgery.com/'>Mark O'Donnell Vascular Surgery</a>.</p></p>        <div><a href='https://newsramp.com/blockchain/txn_detail/b4a57379a98a1b5294abf4271d3e0646.37426.bcuuid 'style='display: flex; align-items: flex-start;'><img src='https://cdn.newsramp.net/qrcode/b4a57379a98a1b5294abf4271d3e0646.webp' class='newsramp-qrcode' style='width: 200px; max-width: 300px; margin-bottom: 25px;'  alt='Blockchain Registration, Verification & Enhancement provided by NewsRamp\u2122'/></a><p>This news story relied on content distributed by <a href='https://mediawiretoday.com'>Press Services</a>.  Blockchain Registration, Verification &amp; Enhancement provided by <a href='https://newsramp.com'>NewsRamp\u2122.</a> The source URL for this press release is <a href='https://newsramp.com/news/press-services/en/consultant-led-vascular-care-model-operates-across-belfast-facilities-444800/b4a57379a98a1b5294abf4271d3e0646'>Belfast Vascular Surgeon Expands to 850+ Procedures Annually.</a></p></div>        </article>    ", "published": "2026-08-19T06:55:01+00:00", "audio_release": "https://cdn.newsramp.net/audio/b4a57379a98a1b5294abf4271d3e0646.mp3", "blockchain_qrcode": "https://cdn.newsramp.net/qrcode/b4a57379a98a1b5294abf4271d3e0646.webp", "enclosure": "https://cdn.newsramp.app/press-services/newsimage/b4a57379a98a1b5294abf4271d3e0646.jpg", "site_handle": "press-services", "seo_description": "Professor Mark O'Donnell expands Belfast practice to 850+ minimally invasive vascular procedures yearly, offering consultant-led varicose veins treatment in Northern Ireland.", "newsramp_curated": "https://newsramp.com/curated-news/belfast-vascular-surgeon-expands-to-850-procedures-annually/b4a57379a98a1b5294abf4271d3e0646"}, {"feed_item_id": 37402, "prhash_id": "ce6e45fd0914621f1e20ec08fe830408", "headline": "Regentis Biomaterials Strengthens GelrinC Manufacturing and IP with New Patents", "content": "        <article>        <h1>Regentis Biomaterials Strengthens GelrinC Manufacturing and IP with New Patents</h1>        <img src='https://cdn.newsramp.app/banners/business-corporate-1.jpg' style='width:80%; display: block; margin-left: auto; margin-right: auto; margin-top:1rem; margin-bottom:1rem;' alt='Regentis Biomaterials Strengthens GelrinC Manufacturing and IP with New Patents'/>        <h2>Key Takeaways (TLDR)</h2>        <ul>            <li>Regentis secures Japanese patent for GelrinC, expanding IP to nearly 30 patents, and boosts yield fivefold, positioning ahead in cartilage repair.</li>            <li>Regentis's organic solvent-free manufacturing process increases yield fivefold, simplifies production, and supports commercial scale for GelrinC.</li>            <li>Regentis's off-the-shelf GelrinC offers a simpler, cost-effective alternative to cell-based procedures, potentially improving access to knee cartilage repair for many.</li>            <li>GelrinC is a cell-free hydrogel that resorbs in the knee, prompting surrounding cells to regenerate cartilage\u2014a novel approach to tissue repair.</li>        </ul>        <h2>Why it Matters</h2>        <p>This news matters because Regentis Biomaterials is overcoming key barriers to commercialization of its off-the-shelf cartilage repair product, GelrinC. The enhanced manufacturing process and expanded patent portfolio not only reduce production costs and complexity but also protect the technology in key markets, including Japan and the U.S. For patients suffering from knee cartilage damage, GelrinC could offer a more accessible and less invasive treatment option than existing cell-based therapies. For investors, these milestones signal the company's progress toward regulatory approval and market entry, potentially positioning Regentis as a leader in the regenerative medicine space.</p>        <h2>Summary</h2>        <p><p>Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC cartilage-repair technology with significant manufacturing and intellectual property milestones. The company recently received a Japanese Notice of Allowance for patent protection covering its organic solvent-free manufacturing process and ready-to-use liquid formulation, following a U.S. issuance that expanded its global IP portfolio to nearly 30 patents. This proprietary process increases yield fivefold, simplifies production, and is designed for commercial-scale manufacturing, positioning GelrinC as an off-the-shelf alternative to complex and costly cell-based procedures.</p><p>As Regentis progresses toward broader commercialization, it has begun European commercialization efforts following CE Mark approval and is advancing its pivotal U.S. trial beyond 50% enrollment, with premarket approval preparation targeted for the end of 2027. GelrinC addresses a market of approximately 470,000 cases for cartilage knee repair annually in the U.S., where no off-the-shelf treatment currently exists. To view the full article, visit <a href='https://ibn.fm/ILwoP' rel='noreferrer noopener'>https://ibn.fm/ILwoP</a>.</p><p>Regentis Biomaterials is a regenerative medicine company focused on developing innovative tissue repair solutions, with its Gelrin platform technology based on synchronized, degradable hydrogel implants. The company's lead product, GelrinC(R), is a cell-free hydrogel that regenerates damaged cartilage in the knee. This content has been disseminated on behalf of Regentis Biomaterials Ltd. (NASDAQ: RGNT) as part of a paid investor awareness and marketing engagement, and the latest news and updates are available in the company's newsroom at <a href='https://www.investorbrandnetwork.com/clients/regentis-biomaterials-ltd/' rel='noreferrer noopener'>https//ibn.fm/RGNT</a>.</p></p>        <div><a href='https://newsramp.com/blockchain/txn_detail/ce6e45fd0914621f1e20ec08fe830408.37402.bcuuid 'style='display: flex; align-items: flex-start;'><img src='https://cdn.newsramp.net/qrcode/ce6e45fd0914621f1e20ec08fe830408.webp' class='newsramp-qrcode' style='width: 200px; max-width: 300px; margin-bottom: 25px;'  alt='Blockchain Registration, Verification & Enhancement provided by NewsRamp\u2122'/></a><p>This news story relied on content distributed by <a href='https://investorbrandnetwork.com'>InvestorBrandNetwork (IBN)</a>.  Blockchain Registration, Verification &amp; Enhancement provided by <a href='https://newsramp.com'>NewsRamp\u2122.</a> The source URL for this press release is <a href='https://newsramp.com/news/ibn/en//ce6e45fd0914621f1e20ec08fe830408'>Regentis Biomaterials Strengthens GelrinC Manufacturing and IP with New Patents.</a></p></div>        </article>    ", "published": "2026-08-18T18:00:36+00:00", "audio_release": "https://cdn.newsramp.net/audio/ce6e45fd0914621f1e20ec08fe830408.mp3", "blockchain_qrcode": "https://cdn.newsramp.net/qrcode/ce6e45fd0914621f1e20ec08fe830408.webp", "enclosure": "https://cdn.newsramp.app/banners/business-corporate-1.jpg", "site_handle": "ibn", "seo_description": "Regentis Biomaterials gains Japanese patent for GelrinC manufacturing, expands IP to nearly 30 patents, advances commercialization and pivotal U.S. trial.", "newsramp_curated": "https://newsramp.com/curated-news/regentis-biomaterials-strengthens-gelrinc-manufacturing-and-ip-with-new-patents/ce6e45fd0914621f1e20ec08fe830408"}, {"feed_item_id": 37400, "prhash_id": "7846cef955e3ae0b160c6ffdda9bd941", "headline": "VERAXA Biotech and Ardigen Team Up to Use AI in Oncology Drug Discovery", "content": "        <article>        <h1>VERAXA Biotech and Ardigen Team Up to Use AI in Oncology Drug Discovery</h1>        <img src='https://cdn.newsramp.app/banners/technology-6.jpg' style='width:80%; display: block; margin-left: auto; margin-right: auto; margin-top:1rem; margin-bottom:1rem;' alt='VERAXA Biotech and Ardigen Team Up to Use AI in Oncology Drug Discovery'/>        <h2>Key Takeaways (TLDR)</h2>        <ul>            <li>VERAXA Biotech's AI collaboration with Ardigen could streamline oncology drug development, giving it an edge in the competitive biotech market.</li>            <li>VERAXA Biotech uses Ardigen's AI to analyze genomic data, identifying dual-target combinations for safer, more effective cancer therapies.</li>            <li>VERAXA Biotech's AI-driven approach may resurrect abandoned cancer drugs, offering new hope for patients with limited treatment options.</li>            <li>VERAXA Biotech's 'AND-gated' technology, which activates only when two cancer targets meet, is a novel twist in drug design.</li>        </ul>        <h2>Why it Matters</h2>        <p>This partnership matters because it leverages artificial intelligence to optimize the development of cancer therapies, potentially leading to more effective and safer treatments for patients. By combining VERAXA's innovative BiTAC platform with Ardigen's AI capabilities, the collaboration could accelerate drug discovery, reduce costs, and improve the success rate of clinical trials. Additionally, revisiting previously abandoned targets with AI analysis may uncover new therapeutic opportunities, expanding the arsenal against cancer. For investors, this underscores the growing role of AI in biotech, making VERAXA a company to watch.</p>        <h2>Summary</h2>        <p><p>VERAXA Biotech (NASDAQ: VRXA) was recently highlighted in an article for its collaboration with Ardigen, an AI-focused research organization, aiming to strengthen its oncology pipeline through the integration of artificial intelligence in drug discovery. By leveraging Ardigen's expertise in AI, computational biology, and bioinformatics, combined with VERAXA's proprietary BiTAC(R) platform, the partnership seeks to identify optimal dual-target combinations for T-cell engagers and antibody-drug conjugates, improve target validation, and reduce development risks. VERAXA's 'AND-gated' approach, which activates therapies only when two cancer-associated targets are present on the same cell, is particularly suited to AI-driven analysis of complex genomic, proteomic, and clinical datasets. This technology could also enable researchers to revisit historical data and potentially identify safer applications for targets or therapies previously abandoned due to toxicity concerns.</p><p>VERAXA is building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including bispecific T cell engagers, bispecific ADCs, and other innovative formats. Powered by transformative technologies and guided by quality-by-design principles, the company is rapidly advancing its pipeline into clinical development. Founded on scientific breakthroughs at the European Molecular Biology Laboratory, VERAXA continues to innovate in the field. For more details, visit the full article at https://ibn.fm/2U2hQ and check out VERAXA's updates at www.VERAXA.com.</p><p>InvestorWire, a specialized communications platform, distributed this news, offering advanced press release syndication for companies and the investment community. With a wide network and seasoned journalists, InvestorWire helps clients gain recognition and brand awareness. This collaboration signifies a step forward in using AI to enhance cancer therapy development, potentially leading to more effective and safer treatments.</p></p>        <div><a href='https://newsramp.com/blockchain/txn_detail/7846cef955e3ae0b160c6ffdda9bd941.37400.bcuuid 'style='display: flex; align-items: flex-start;'><img src='https://cdn.newsramp.net/qrcode/7846cef955e3ae0b160c6ffdda9bd941.webp' class='newsramp-qrcode' style='width: 200px; max-width: 300px; margin-bottom: 25px;'  alt='Blockchain Registration, Verification & Enhancement provided by NewsRamp\u2122'/></a><p>This news story relied on content distributed by <a href='https://investorbrandnetwork.com'>InvestorBrandNetwork (IBN)</a>.  Blockchain Registration, Verification &amp; Enhancement provided by <a href='https://newsramp.com'>NewsRamp\u2122.</a> The source URL for this press release is <a href='https://newsramp.com/news/ibn/en//7846cef955e3ae0b160c6ffdda9bd941'>VERAXA Biotech and Ardigen Team Up to Use AI in Oncology Drug Discovery.</a></p></div>        </article>    ", "published": "2026-08-18T17:32:00+00:00", "audio_release": "https://cdn.newsramp.net/audio/7846cef955e3ae0b160c6ffdda9bd941.mp3", "blockchain_qrcode": "https://cdn.newsramp.net/qrcode/7846cef955e3ae0b160c6ffdda9bd941.webp", "enclosure": "https://cdn.newsramp.app/banners/technology-6.jpg", "site_handle": "ibn", "seo_description": "VERAXA Biotech partners with Ardigen to use AI for optimizing oncology pipeline. Learn how their BiTAC platform and AI-driven analysis could enhance cancer therapy development.", "newsramp_curated": "https://newsramp.com/curated-news/veraxa-biotech-and-ardigen-team-up-to-use-ai-in-oncology-drug-discovery/7846cef955e3ae0b160c6ffdda9bd941"}, {"feed_item_id": 37399, "prhash_id": "5f03542c126a903d8b56aa812e80109a", "headline": "VERAXA Biotech and Ardigen Join Forces to Apply AI in Oncology Drug Discovery", "content": "        <article>        <h1>VERAXA Biotech and Ardigen Join Forces to Apply AI in Oncology Drug Discovery</h1>        <img src='https://cdn.newsramp.app/banners/technology-2.jpg' style='width:80%; display: block; margin-left: auto; margin-right: auto; margin-top:1rem; margin-bottom:1rem;' alt='VERAXA Biotech and Ardigen Join Forces to Apply AI in Oncology Drug Discovery'/>        <h2>Key Takeaways (TLDR)</h2>        <ul>            <li>VERAXA's AI-driven BiTAC platform could outpace rivals in oncology by identifying optimal dual-target combos and reducing development risks.</li>            <li>VERAXA (VRXA) uses Ardigen's AI to analyze genomic, proteomic, and clinical data, optimizing BiTAC T-cell engagers and ADCs via dual-target validation.</li>            <li>AI-enhanced dual-targeting therapies may revive abandoned cancer drugs, offering safer treatments and potentially saving more lives.</li>            <li>VERAXA's 'AND-gated' therapy only activates when two cancer targets meet, an innovative approach powered by AI from Ardigen.</li>        </ul>        <h2>Why it Matters</h2>        <p>This collaboration matters because AI is poised to transform drug discovery, and VERAXA's partnership with Ardigen could lead to more effective and safer cancer treatments. By using AI to identify optimal target combinations and revisit abandoned drugs, this approach has the potential to expedite the development of next-generation therapies, ultimately offering new hope to patients and creating value for investors.</p>        <h2>Summary</h2>        <p><p>VERAXA Biotech (NASDAQ: VRXA) is making headlines with its strategic collaboration with AI-focused research organization Ardigen, aiming to revolutionize oncology drug discovery. By integrating Ardigen's expertise in artificial intelligence, computational biology, and bioinformatics with VERAXA's proprietary BiTAC(R) platform, the partnership seeks to harness AI to identify optimal dual-target combinations for T-cell engagers and antibody-drug conjugates. This approach not only enhances target validation but also mitigates development risks, potentially accelerating the path to market for next-generation cancer therapies. VERAXA's innovative 'AND-gated' mechanism, which activates therapies only when two cancer-associated targets are present on the same cell, is particularly well-suited for AI-driven analysis of complex biological data. This could enable researchers to mine historical clinical and preclinical datasets, potentially resurrecting previously abandoned targets due to toxicity concerns, now deemed safer with improved precision.</p><p>The collaboration underscores the growing role of artificial intelligence in drug discovery, a trend that is reshaping the pharmaceutical landscape. VERAXA, built on breakthroughs from the European Molecular Biology Laboratory, is dedicated to advancing antibody-based therapeutics, including bispecific T cell engagers and ADCs. With this partnership, the company aims to leverage AI to not only improve the efficacy of its pipeline but also to reduce the time and cost associated with bringing new cancer treatments to patients. The recent article, accessible via <a href='https://ibn.fm/2U2hQ' rel='noreferrer noopener'>https://ibn.fm/2U2hQ</a>, provides deeper insights into this exciting development. As VERAXA continues to progress its pipeline, investors and industry observers are keenly watching how this AI-driven strategy will unfold, potentially positioning the company as a leader in precision oncology. For ongoing updates, the company's newsroom at <a href='https://ibn.fm/VRXA' rel='noreferrer noopener'>https://ibn.fm/VRXA</a> offers the latest information.</p></p>        <div><a href='https://newsramp.com/blockchain/txn_detail/5f03542c126a903d8b56aa812e80109a.37399.bcuuid 'style='display: flex; align-items: flex-start;'><img src='https://cdn.newsramp.net/qrcode/5f03542c126a903d8b56aa812e80109a.webp' class='newsramp-qrcode' style='width: 200px; max-width: 300px; margin-bottom: 25px;'  alt='Blockchain Registration, Verification & Enhancement provided by NewsRamp\u2122'/></a><p>This news story relied on content distributed by <a href='https://investorbrandnetwork.com'>InvestorBrandNetwork (IBN)</a>.  Blockchain Registration, Verification &amp; Enhancement provided by <a href='https://newsramp.com'>NewsRamp\u2122.</a> The source URL for this press release is <a href='https://newsramp.com/news/ibn/en//5f03542c126a903d8b56aa812e80109a'>VERAXA Biotech and Ardigen Join Forces to Apply AI in Oncology Drug Discovery.</a></p></div>        </article>    ", "published": "2026-08-18T17:13:38+00:00", "audio_release": "https://cdn.newsramp.net/audio/5f03542c126a903d8b56aa812e80109a.mp3", "blockchain_qrcode": "https://cdn.newsramp.net/qrcode/5f03542c126a903d8b56aa812e80109a.webp", "enclosure": "https://cdn.newsramp.app/banners/technology-2.jpg", "site_handle": "ibn", "seo_description": "VERAXA Biotech partners with Ardigen to use AI in oncology drug discovery, enhancing target validation and reducing risks. Learn how this collaboration could shape future cancer treatments.", "newsramp_curated": "https://newsramp.com/curated-news/veraxa-biotech-and-ardigen-join-forces-to-apply-ai-in-oncology-drug-discovery/5f03542c126a903d8b56aa812e80109a"}]}